Technology in the management of type 2 diabetes: Present status and future prospects

Abstract

The growing incidence of type 2 diabetes (T2D) is a significant health concern, representing 90% of diabetes cases worldwide. As the disease progresses, resultant insulin deficiency and hyperglycaemia necessitates insulin therapy in many cases. It has been recognized that a significant number of people who have a clinical requirement for insulin therapy, as well as their healthcare professionals, are reluctant to intensify treatment with insulin due to fear of hypoglycaemia, poor understanding of treatment regimens or lack of engagement, and are therefore at higher risk of developing complications from poor glycaemic control. Over the past decade, the rise of diabetes technologies, including dosing advisors, continuous glucose monitoring systems, insulin pumps and automated insulin delivery systems, has led to great improvements in the therapies available, particularly to those requiring insulin. Although the focus has

Apoptotic susceptibility of pancreatic alpha cells to environmentally relevant dose levels of bisphenol‐A versus dibutyl phthalate is mediated by HSP60/caspase‐3 expression in male albino rats

“…Diabetes mellitus (DM) is a worldwide health problem, and the prevalence rate of DM is increasing rapidly across the globe, from 488 million cases in 2019 to 592 million cases by 2035. Type 2 diabetes constitutes about 90% of all global cases with an 8.3% prevalence rate (Daly & Hovorka, 2021). The pathogenesis of DM is multifactorial including not only genetic background and lifestyle factors (Lloyd et al, 2021), but also early life exposure to environmental factors, has been linked to the development of type 2 diabetes (Zheng et al, 2022).…”

Self-Care Experiences of Empty-Nest Elderly Living With Type 2 Diabetes Mellitus: A Qualitative Study From China

“…The utilization of technology provided more resources for motivation, self-monitoring, personalized education, and promoting the homogenization of medical services, which were facilitators for improving self-care behavior and glycemic control, especially in rural areas ( 36 , 37 ). Meanwhile, there is a need to provide less complex technologies for those elderly patients with impaired cognition and limited technical ability ( 38 ). Our study showed that support from spouses and peers was vital for helping elderly patients to maintain self-care.…”

A Systematic Review and Meta-Analysis of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections in Type-2 Diabetes

“…To date, technology has been used only in T1DM. The pathophysiology of T2DM differs, in that the pancreas is still excreting insulin, but there is evidence that CSII could improve glycemic control as it does in T1DM [ 13 ].…”